Effects of Dry Needling on Neck and Shoulder Pain in Orchestral Musicians: a Prospective Case Series
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03402867 |
|
Recruitment Status :
Completed
First Posted : January 18, 2018
Last Update Posted : July 6, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pain Syndrome Musculoskeletal Pain Trigger Point Pain, Myofascial | Procedure: Deep dry needling | Phase 1 Phase 2 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 8 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Intervention Model Description: | Deep dry needling |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Myofascial Trigger Point Dry Needling on Neck Pain in Orchestral Musicians |
| Actual Study Start Date : | February 1, 2018 |
| Actual Primary Completion Date : | March 1, 2018 |
| Actual Study Completion Date : | March 5, 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention
Deep dry needling applied on active myofascial trigger points in the shoulder and neck regions
|
Procedure: Deep dry needling
Insertion of a filiform needle in the active trigger point of musculoskeletal muscle |
- Visual analogue scale for pain [ Time Frame: 2 weeks ]Pain measurement. 100-mm visual analog scale (VAS), horizontal line ranging from 0mm (no pain) to 100mm (worst imaginable pain).
- Pressure pain threshold [ Time Frame: 2 weeks ]Analogic algometer
- Neck disability index (NDI) [ Time Frame: 2 weeks ]10-item, 50-point index that assesses different aspects of daily functioning in patients with neck pain. It assesses four items regarding subjective symptoms (pain intensity, headache, concentration, sleeping), four items regarding activities of daily living (lifting, work, driving, recreation), and two items regarding discretionary activities of daily living (personal care, reading). Each item is scored 0 to 5, with the total reported as either a raw score (0-50) or as a percentage score. Higher values represent a worse outcome.
- Shoulder pain disability index (SPADI) [ Time Frame: 2 weeks ]Self-administered questionnaire, grouping 13 questions, 5 of which measure the severity of pain caused by various arm movements involving the shoulder, the pain being assessed on a numeric pain scale ranging from 0 to 10. Eight additional questions related to functional impairments of the shoulder are assessed with a numeric scale. Higher values represent a worse outcome.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Orchestral musicians
- Chronic neck or shoulder pain
- Presence of active myofascial trigger points
Exclusion Criteria:
- Fear of needles
- Coagulation disorders
- Pregnancy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03402867
| Spain | |
| CEU San Pablo University | |
| Madrid, Comunidad De Madrid, Spain, 28668 | |
| Responsible Party: | Aitor Martin-Pintado Zugasti, PhD, CEU San Pablo University |
| ClinicalTrials.gov Identifier: | NCT03402867 |
| Other Study ID Numbers: |
CEU-012 |
| First Posted: | January 18, 2018 Key Record Dates |
| Last Update Posted: | July 6, 2018 |
| Last Verified: | July 2018 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Musculoskeletal Pain Myofascial Pain Syndromes Muscular Diseases |
Musculoskeletal Diseases Pain Neurologic Manifestations |

